According to Dr Saumya, genetic predisposition significantly influences the development and severity of non-alcoholic fatty liver disease (NAFLD). Variants in genes such as PNPLA3, TM6SF2 and others alter hepatic lipid handling and fibrosis susceptibility, highlighting that heritable genomic factors interact with metabolic processes to modulate disease risk and progression.